Modulation of intracellular copper levels as the mechanism of action of anticancer copper complexes: Clinical relevance

MV Babak, D Ahn - Biomedicines, 2021 - mdpi.com
Copper (Cu) is a vital element required for cellular growth and development; however, even
slight changes in its homeostasis might lead to severe toxicity and deleterious medical …

Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders

SM Stanford, N Bottini - Nature Reviews Drug Discovery, 2023 - nature.com
Protein phosphatases act as key regulators of multiple important cellular processes and are
attractive therapeutic targets for various diseases. Although extensive effort has been …

Genomics and evolution of protein phosphatases

MJ Chen, JE Dixon, G Manning - Science signaling, 2017 - science.org
Protein phosphatases are the essential opposite to protein kinases; together, these enzymes
regulate all protein phosphorylation and most cellular processes. To better understand the …

[HTML][HTML] Chemical probes and drug leads from advances in synthetic planning and methodology

CJ Gerry, SL Schreiber - Nature Reviews Drug Discovery, 2018 - nature.com
Screening of small-molecule libraries is a productive method for identifying both chemical
probes of disease-related targets and potential starting points for drug discovery. In this …

Protein tyrosine phosphatases as potential therapeutic targets

R He, Z Yu, R Zhang, Z Zhang - Acta pharmacologica sinica, 2014 - nature.com
Protein tyrosine phosphorylation is a key regulatory process in virtually all aspects of cellular
functions. Dysregulation of protein tyrosine phosphorylation is a major cause of human …

The JAK/STAT pathway in obesity and diabetes

EN Gurzov, WJ Stanley, EG Pappas… - The FEBS …, 2016 - Wiley Online Library
Diabetes mellitus are complex, multi‐organ metabolic pathologies characterized by
hyperglycemia. Emerging evidence shows that the highly conserved and potent JAK/STAT …

Targeting the disordered C terminus of PTP1B with an allosteric inhibitor

N Krishnan, D Koveal, DH Miller, B Xue… - Nature chemical …, 2014 - nature.com
PTP1B, a validated therapeutic target for diabetes and obesity, has a critical positive role in
HER2 signaling in breast tumorigenesis. Efforts to develop therapeutic inhibitors of PTP1B …

Drugging undruggable molecular cancer targets

JS Lazo, ER Sharlow - Annual review of pharmacology and …, 2016 - annualreviews.org
Cancer, more than any other human disease, now has a surfeit of potential molecular targets
poised for therapeutic exploitation. Currently, a number of attractive and validated cancer …

Targeting tyrosine phosphatases: time to end the stigma

SM Stanford, N Bottini - Trends in Pharmacological Sciences, 2017 - cell.com
Protein tyrosine phosphatases (PTPs) are a family of enzymes essential for numerous
cellular processes, and several PTPs have been validated as therapeutic targets for human …

Recent advance on PTP1B inhibitors and their biomedical applications

B Sharma, L Xie, F Yang, W Wang, Q Zhou… - European Journal of …, 2020 - Elsevier
Abstract Protein Tyrosine Phosphatase 1B (PTP1B), as one of the most important members
in PTP superfamily, plays a vital role in conducting various cellular functions. So far, PTP1B …